{"id":"https://genegraph.clinicalgenome.org/r/7736bf75-fe84-40f6-bef7-f9a6b8bb2b9cv1.1","type":"EvidenceStrengthAssertion","dc:description":"*PRPF31* was first reported in relation to an inherited retinal dystrophy, described as autosomal dominant retinitis pigmentosa (adRP), in 2001 (Vithana et al., PMID: 11545739). To account for a spectrum of retinal phenotypes that may be caused by variants in this gene, and in accordance with the ClinGen Lumping and Splitting guidelines, the disease entity used for this curation is PRPF31-related retinopathy. This condition is characterized by night blindness (onset in teens), progressive visual loss, and blindness (onset in 30s).\n\nTen variants (missense, in-frame indel, nonsense, frameshift, complex rearrangement) that have been reported in 10 probands in 06 publications (PMIDs: 11545739, 12714658, 12923864, 23288994, 29375987, 20939871) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Interestingly, incomplete penetrance has been frequently observed in families with *PRPF31* pathogenic variants. There are over 200 *PRPF31* pathogenic and likely pathogenic variants listed on ClinVar (07/05/2022).\n\nThe mechanism of pathogenicity is reported to be LOF. This gene-disease relationship is also supported by functional studies in patient derived organoids and retinal pigment epithelium, and *Prpf31+/-* mouse (PMIDs: 30315276, 20811066). \n\nIn summary, *PRPF31* is definitively associated with PRPF31-releated retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This clinical validity classification was approved by the ClinGen Retina GCEP on July 7, 2022 (SOP v9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7736bf75-fe84-40f6-bef7-f9a6b8bb2b9c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-12-31T07:28:44.279Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-07-07T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb12455a-aca6-4b14-816a-36cb37b9d282","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39c474a0-c33d-4ff4-b493-d87ccd39c411","type":"Finding","dc:description":"A significant difference in wild-type PRPF31 mRNA levels was observed between symptomatic and asymptomatic individuals (P < 0.001) and was supported by Western blot analysis of the PRPF31 protein.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14507862","rdfs:label":"Expression analysis of PRPF31 mRNA","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ca3d626-4816-4f77-902c-77503065353a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5654d4e8-7d08-4642-a85d-763cd7c35ab9","type":"Finding","dc:description":"This PRPF31 knockout mice showed late-onset degenerative changes in the RPE of the retina which is critical for photoreceptor structure and function. This phenomenon was not observed in the control mice which validates that PRPF31 haploinsufficiency creates a retina specific phenotype in the model animal mice which is consistent with PRPF31 LoF variants causing adRP in humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20811066","rdfs:label":"PRPF31+/- Knockout mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e60bbaa7-1c93-4821-84f3-c4adf38c08d8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e60bbaa7-1c93-4821-84f3-c4adf38c08d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","allele":{"id":"https://genegraph.clinicalgenome.org/r/d9c05110-29a2-4cbc-ab3c-15d171103937","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.732_737delinsTGCAGAGGCCTGACCAACCT (p.Met244IlefsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130425"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/24949bfa-2096-4e2c-92b4-1e8828ce3799","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24949bfa-2096-4e2c-92b4-1e8828ce3799_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29375987","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b8e2b08-83ef-468d-a1fc-f7611766ce1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.358_359del (p.Lys120fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499225590"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/72903936-2b44-49c3-8d86-2c5c095659e2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72903936-2b44-49c3-8d86-2c5c095659e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","allele":{"id":"https://genegraph.clinicalgenome.org/r/be6bf2fb-483c-4bb5-9e16-ba40387d039b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.544_618del (p.Glu182_Glu206del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130427"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/72903936-2b44-49c3-8d86-2c5c095659e2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"mRNA expression assay revealed that the mRNA expression level of the PRPF31 and RP9 genes were significantly lower in RP patients than controls (p<0.05). The in vitro transfection assay demonstrated that the mRNA expression level of the mutant transfection group was significantly lower than the wild-type transfection group (p<0.05).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31d53fee-8e9a-4f31-bbec-9dea05292342","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31d53fee-8e9a-4f31-bbec-9dea05292342_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12923864","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ab09cdc-289c-4ba3-98a8-23a3e3216d87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.332_343del (p.His111_Ile114del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184783"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/32eba8c1-d17e-473d-8363-f45bc43bf104","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32eba8c1-d17e-473d-8363-f45bc43bf104_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11545739","allele":{"id":"https://genegraph.clinicalgenome.org/r/728abbae-e1c2-42de-9dab-ce0360424642","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.1115_1125del (p.Arg372fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253131"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/32eba8c1-d17e-473d-8363-f45bc43bf104_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yes","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/87969c6e-1ce0-497a-85a4-6521e23ab5f1","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87969c6e-1ce0-497a-85a4-6521e23ab5f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","allele":{"id":"https://genegraph.clinicalgenome.org/r/e5215a54-2d4f-4eae-9538-a937f1f0a962","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.828_829del (p.His276GlnfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130426"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/50f32f61-4b54-49f6-a754-1686135bd8ae","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50f32f61-4b54-49f6-a754-1686135bd8ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9316dc3-7a9e-4ff6-8703-b0e2b70419da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.770dup (p.Thr258fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184784"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/50f32f61-4b54-49f6-a754-1686135bd8ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant zebrafish showed that this variant leads to an unstable protein that is mislocalized to the rod cytoplasm. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0d58aa83-5a69-4f2a-85bc-6928a2d4423d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d58aa83-5a69-4f2a-85bc-6928a2d4423d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20939871","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc2dddda-11e1-469e-9db0-39425d8ac444","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.54123562T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407750419"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/230758cd-0b12-46e6-b9cb-4f717884d755","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/230758cd-0b12-46e6-b9cb-4f717884d755_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","allele":{"id":"https://genegraph.clinicalgenome.org/r/2878356c-f57b-4bca-a2af-f3715e06297c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.615del (p.Tyr205Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130428"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/81f354cf-29c2-4955-a09d-735463f16a35_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/135751b9-01be-4cde-9219-dfefa39e30be_proband_segregation","type":"FamilyCosegregation","dc:description":"Maximus 2.8 LOD score was obtained on STR marker (D19S418) close to PRPF31 gene, therefore PRPF31 gene was sequenced. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12923864","rdfs:label":"Wang_kindred_RPYT","estimatedLodScore":5.72,"family":{"id":"https://genegraph.clinicalgenome.org/r/135751b9-01be-4cde-9219-dfefa39e30be","type":"Family","rdfs:label":"Wang_kindred_RPYT","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dfb0d57f-827a-4111-85b6-5535fd878251","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12923864","rdfs:label":"Wang_kindred_RPYT_2","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ab09cdc-289c-4ba3-98a8-23a3e3216d87"},"detectionMethod":"Linkage analysis was performed by using STR markers for loci associated with adRP (RHO, RDS, NRL, RP1, CRX, FSCN2, RP9, RP10, RP11, RP13, RP17, and RP18). After getting a positive linkage, SSCP was performed for mutational screen which was followed by Sanger sequencing to detect the causal variant in PRPF31 gene. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/31d53fee-8e9a-4f31-bbec-9dea05292342_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":20,"proband":{"id":"https://genegraph.clinicalgenome.org/r/dfb0d57f-827a-4111-85b6-5535fd878251"},"publishedLodScore":2.8,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ddc8cb16-b42b-438d-ad60-0a9b1c0cc279_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_S240","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/ddc8cb16-b42b-438d-ad60-0a9b1c0cc279","type":"Family","rdfs:label":"Gimeno_S240","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/d8004f12-b473-4975-a394-2a96149c82ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_S240_III_1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d9c05110-29a2-4cbc-ab3c-15d171103937"},"detectionMethod":"Denaturing gradient gel electrophoresis (DGGE) was first used for mutation analysis of coding regions of PRPF31, PRPF8 and PRPF3 genes. This was followed by Sanger sequencing to identify the variants. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Other","phenotypes":"obo:HP_0000510","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e60bbaa7-1c93-4821-84f3-c4adf38c08d8_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/d8004f12-b473-4975-a394-2a96149c82ee"}},{"id":"https://genegraph.clinicalgenome.org/r/72142d25-5e3c-42ea-8acb-b3f2f72490c7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_LLN","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/72142d25-5e3c-42ea-8acb-b3f2f72490c7","type":"Family","rdfs:label":"Xu_ADRP_LLN","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7a501715-056e-4996-a95d-c78464f7ff37","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_LLN_III_1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2878356c-f57b-4bca-a2af-f3715e06297c"},"detectionMethod":"Sanger sequencing of all coding exons of PRPF31 was performed to identify disease causing variants.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000006","obo:HP_0007843","obo:HP_0007737","obo:HP_0000662","obo:HP_0007663","obo:HP_0000510"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/230758cd-0b12-46e6-b9cb-4f717884d755_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0007843","obo:HP_0000662","obo:HP_0007663","obo:HP_0007737","obo:HP_0000510","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7a501715-056e-4996-a95d-c78464f7ff37"}},{"id":"https://genegraph.clinicalgenome.org/r/8f724574-dd22-41d3-aec6-664d032b8908_proband_segregation","type":"FamilyCosegregation","dc:description":"Direct Sanger sequencing of PRPF31 gene was performed because of the strong autosomal dominant history of RP in the family.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_LG","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/8f724574-dd22-41d3-aec6-664d032b8908","type":"Family","rdfs:label":"Xu_ADRP_LG","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7b24bd48-1c46-45fe-86bd-cba48b7e0882","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_LG_III_9","ageType":"AgeAtReport","ageUnit":"Years","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/be6bf2fb-483c-4bb5-9e16-ba40387d039b"},"detectionMethod":"Sanger sequencing of all coding exons of PRPF31 was performed to identify disease causing variants","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0007737","obo:HP_0007663","obo:HP_0007843","obo:HP_0003829","obo:HP_0000662","obo:HP_0000512","obo:HP_0000510","obo:HP_0000006"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/72903936-2b44-49c3-8d86-2c5c095659e2_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0000006","obo:HP_0003829","obo:HP_0007843","obo:HP_0000662","obo:HP_0000510","obo:HP_0007737","obo:HP_0007663","obo:HP_0000512"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7b24bd48-1c46-45fe-86bd-cba48b7e0882"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/c97d6d56-91c9-4633-b285-99aaa0d9af63_proband_segregation","type":"FamilyCosegregation","dc:description":"Direct Sanger sequencing of PRPF31 gene was performed because of the strong autosomal dominant  history of RP in the family.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_XL","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/c97d6d56-91c9-4633-b285-99aaa0d9af63","type":"Family","rdfs:label":"Xu_ADRP_XL","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5b354813-da53-4cca-8150-0844d94e6e41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","rdfs:label":"Xu_ADRP_XL_VI_1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/06db3a01-053a-43d6-88a4-ab6b0cd6bc3e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015629.4(PRPF31):c.895T>C (p.Cys299Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407751847"}},"detectionMethod":"Sanger sequencing of all coding exons of PRPF31 was performed to identify disease causing variants. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000518","obo:HP_0007737","obo:HP_0000510","obo:HP_0007843","obo:HP_0000006","obo:HP_0007663","obo:HP_0003829","obo:HP_0000512"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fb584aab-3ed3-44c0-a538-5ba726ac9667_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23288994","allele":{"id":"https://genegraph.clinicalgenome.org/r/06db3a01-053a-43d6-88a4-ab6b0cd6bc3e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0007663","obo:HP_0000518","obo:HP_0007737","obo:HP_0000512","obo:HP_0007843","obo:HP_0000510","obo:HP_0000006","obo:HP_0003829"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5b354813-da53-4cca-8150-0844d94e6e41"},"publishedLodScore":2.09,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6766a9d5-cefa-4608-be40-d1f57bde6267_proband_segregation","type":"FamilyCosegregation","dc:description":"In refined linkage map, only two known genes (PRKCG and RPS9) and several predicted genes were present. The known genes PRKCG and RPS9 were excluded and then disease causing variants were identified in PRPF31 gene. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11545739","rdfs:label":"AD5","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/6766a9d5-cefa-4608-be40-d1f57bde6267","type":"Family","rdfs:label":"AD5","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/01f3f9f2-c370-4d2e-befe-3aa527f63111","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11545739","rdfs:label":"Vithana_AD5_1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/728abbae-e1c2-42de-9dab-ce0360424642"},"detectionMethod":"Positional cloning approach supported by bioinformatics was deployed to identify the gene on the locus previously identified by al-Maghtheh et al., 1994 (PMID: 8004108). This was followed by Sanger sequencing of the gene to identify the variants. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/32eba8c1-d17e-473d-8363-f45bc43bf104_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0000510","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/01f3f9f2-c370-4d2e-befe-3aa527f63111"},"publishedLodScore":4.87,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d4989b21-909e-4bd4-be81-80ea9292e0b4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_M637","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/d4989b21-909e-4bd4-be81-80ea9292e0b4","type":"Family","rdfs:label":"Gimeno_M637","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b10ef1f0-1943-49f9-b297-46ee3648782a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_M637_II_2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f9316dc3-7a9e-4ff6-8703-b0e2b70419da"},"detectionMethod":"Denaturing gradient gel electrophoresis (DGGE) was first used for mutation analysis of coding regions of PRPF31, PRPF8 and PRPF3 genes. This was followed by Sanger sequencing to identify the variants. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Denaturing gradient gel","phenotypes":"obo:HP_0000510","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/50f32f61-4b54-49f6-a754-1686135bd8ae_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/b10ef1f0-1943-49f9-b297-46ee3648782a"}},{"id":"https://genegraph.clinicalgenome.org/r/c463dd56-9d2f-432c-ac9a-4252786a378f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_M368","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/c463dd56-9d2f-432c-ac9a-4252786a378f","type":"Family","rdfs:label":"Gimeno_M368","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2d09cb92-9468-48c5-9e39-cd06eedc12a4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12714658","rdfs:label":"Gimeno_M368_III_2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e5215a54-2d4f-4eae-9538-a937f1f0a962"},"detectionMethod":"Denaturing gradient gel electrophoresis (DGGE) was first used for mutation analysis of coding regions of PRPF31, PRPF8 and PRPF3 genes. This was followed by Sanger sequencing to identify the variants.","firstTestingMethod":"Denaturing gradient gel","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/87969c6e-1ce0-497a-85a4-6521e23ab5f1_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2d09cb92-9468-48c5-9e39-cd06eedc12a4"}},{"id":"https://genegraph.clinicalgenome.org/r/8ec1b459-fce1-476d-bf63-cfeea94ba48e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20939871","rdfs:label":"Audo_F405","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/8ec1b459-fce1-476d-bf63-cfeea94ba48e","type":"Family","rdfs:label":"Audo_F405","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/af06ede2-dfec-45b9-bbc1-097ecf0c32fd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20939871","rdfs:label":"Audo_F405_CIC00607","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cc2dddda-11e1-469e-9db0-39425d8ac444"},"detectionMethod":"Sanger sequencing of all coding exons of PRPF31 was performed to identify disease causing variants.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000662","obo:HP_0000510","obo:HP_0003829","obo:HP_0000006","obo:HP_0000512","obo:HP_0007843","obo:HP_0007737"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0d58aa83-5a69-4f2a-85bc-6928a2d4423d_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000662","obo:HP_0000512","obo:HP_0003829","obo:HP_0007737","obo:HP_0007843","obo:HP_0000006","obo:HP_0000510"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/af06ede2-dfec-45b9-bbc1-097ecf0c32fd"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fb584aab-3ed3-44c0-a538-5ba726ac9667","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb584aab-3ed3-44c0-a538-5ba726ac9667_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5681,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Ku_pi1Cu_cc","type":"GeneValidityProposition","disease":"obo:MONDO_0800395","gene":"hgnc:15446","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_81f354cf-29c2-4955-a09d-735463f16a35-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}